Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H15NO2 |
| Molecular Weight | 241.2851 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC=CC=C1NCCC2=CC=CC=C2
InChI
InChIKey=HLNLBEFKHHCAMV-UHFFFAOYSA-N
InChI=1S/C15H15NO2/c17-15(18)13-8-4-5-9-14(13)16-11-10-12-6-2-1-3-7-12/h1-9,16H,10-11H2,(H,17,18)
Enfenamic acid (under brand name tromaril) is an anthranilic acid derivative with potent anti-inflammatory, anti-arthritic, analgesic and antipyretic actions. It has additional unique property of anti-platelet aggregation activity, without disturbing any other blood coagulation factors. It also differs from other non-steroidal anti-inflammatory agents like indomethacin, in producing diuresis and natriuresis. In the clinical study, tromaril showed itself as a strong and effective drug for use in various eye diseases.
Approval Year
Sample Use Guides
Incubation of liver cells in the presence of 1.0 mM enfenamic acid inhibited the output of glucose. And also the in vitro addition of various concentrations of enfenamic acid (0.25 to 3.0 mM) to the tissue extracts of liver inhibited the activities of important gluconeogenic enzymes such as pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK) and fructose 1,6-diphosphatase (FDPase). These findings indicated that the impairment of gluconeogenesis might be due to the inactivation of the enzymes by the drug.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
31635
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
DTXSID8057693
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
23049-93-6
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
m1133
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL2106178
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
100000080229
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
SUB06529MIG
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
4973
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
C72088
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
C019126
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
05KO5G76R2
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY | |||
|
3176
Created by
admin on Mon Mar 31 18:29:47 GMT 2025 , Edited by admin on Mon Mar 31 18:29:47 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
